Priority Date: 27.01.12 (US 201261591299P)

INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3

  • Application ID: EP13701748
  • Status: █ PATENT GRANTED

Applicant

Technology company logo small
F. Hoffmann-La Roche AG
Technology Company

Attorney

Missing person image small
Jochen Carl Beyermann
no operation time available
F. Hoffmann-La Roche AG
Technology Company

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.01.2012 - Priority Date (US 201261591299P)
  • 01.08.2013 - Publication A1 (WO2013110578)
  • 03.12.2014 - Publication A1 (EP2806899)
  • 19.10.2016 - Publication B1 (EP2806899)

IPC Classification